An Animal Model For Screening Topical And Systemic Drugs For Potential Use In The Treatment Of Psoriasis  by du Vivier, Anthony & Stoughton, Richard B.
T JOURN Al, Of I NVESTIGATI VE D EIlMATOLOG Y, 65:235- 237, 1975 
C H I!: . hl © 1975 by The Willi a ms & Wilkins Co. o p y n g 
Vol. 65, No.2 
Pril1 ted ill U.S. A . 
AN ANIMAL MODEL FOR SCREENING TOPICAL AND SYSTEMIC DRUGS 
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A new ha irless mouse model using ul t rav iolet light to stimulate increased epidermal cell 
t urnOver and hyperplas ia and thus s imulate psori as is ha been des igned so that drugs may 
be tested both to pically and systemically for poss ible thera peuti c value in this disease. T wo 
methods of determining drug ant imi totic act iv ity have been used, the mitotic index and the 
extra.ct ion of epidermal DNA and the dete rminat ion of the radioactivity of t he sampl e. Re-
sul ts show that 2% 5-fluorourac il in propylene glyco l and 2% ni trogen mustard in water 
top ically and cyclophospham ide systemically, which are drugs known to be effective in 
pso ri as is, s ignificantly reduce t he mi totic index. DNA synthes is is s imila rl y dec reased by t he 
latter two drugs . The effect of the topica l age nts is shown to be loca l and not syste mic. Cy-
clophosphamide, which is ineffective topically in psori as is, is ineffecti 'e in the model. 
T h e num ber of effec tive t~ era ~i es for psori asis is 
lim ited . Coa l t a r a nd Its den va tlves, to pica l gluco-
t i costero ids , ultrav IO let li ght, a nd systemic cor . I . t' t h otrexate rem a in t l e ma instays 0 t reatment. ;;~ey have been in use for at least 20 yea rs . Other 
therapies h ave been tri ed. For exa mple, ni trogen 
m u stard [1) , ret inoic ac id [2 ], 5- fluorourac il (3 ), 
h d r oxyurea [4 J, and thiotepa (5 ) have a ll been 
Y d to pi ca. ll y, and hydroxyurea [6 J, 6- mercap-~~;urin e [7] , azathioprine [8.1 , a nd azaribine [9J 
h e been evalu ated systemically, but none can 
r:a\lY be sa id to be superior to establis hed a p-
p roaches. I" It ' I h f'· I Al t hough hum a n c IIllca n a s are t e lil a 
oof of the effi cacy of a drug, t he screening for P~tentia1 antipsoriatic agents should be conducted 
P nim als . T he assess ment of a drug in t he hum an 
in a . I h' I' b' b situat ion is often vl sua w IC 1 IS su Ject to 0 -
serve r error and bias and . a lt hough some . stu~i es 
have used r(li totic counts [1O- 12J, hiStologiC cn te-
ria [11 , 12 ), autora~iography [13 ), an.d i~ .. vi t ro 
techniques (14) which are a more SC ientifi c a p-
proach to the problem, ~lum ero u~ biopsies and the 
intr o duction of radIOactive ma ten als do not consti -
tute a n easy approach t.o sc reening a la rge number 
of p otential antlpson.atl c compou,:ds ra pidly. The 
need for a s imple al1lmal system (or testlll g drugs 
for p otenti a l a n t ipsoria t ic properti es is a pparellt, 
and the mouse vaginal and rectal model of Van 
M a nusc rip t rece ived Decel~be r 5. 1974; in revised form 
February 14, 1975; accepted for publica t ion F ebruary 19, 
19~~search s ponsored by the U. S . Arm y M edical Re -
sear c h a nd De ve lopmen t Command , Washll1 gt on , D. C., 
und e r Con t rac t No. DA 1767. C 7159, and Resea rch Grant 
o. AM 11649 from the Natlol; a l Inst it utes of Hea lth. 
* Senior Regis trar on leave of absence from the Depart -
ment of De rJ1la to logy, St. Ma ry's Hospi ta l, London W2, 
England. 0 R B S · h D·· . Reprint requ ests to: r.. . . toug t.on , IVlSlOn of 
Der matology, SCriPPS ClIm c a nd Researc h Fou nd at ion, 
La Jo ll a, Cali fo rni a 92037 . 
235 
Scott and Bonder (15 ) is a recogni t ion of t his . We 
agree wit h t hem that at t he present t ime the 
t herapy of psori as is is directed toward red ucing cell 
proli fe rat ion and thus restoring ce ll different iation 
to normal. T heir model utili zes mouse vagin a 
because it is s im ila r to psori as iform epidermis in 
t hat its cell replica tion rate is high [16]. Using the 
sa me prin ciples, we have developed a model us ing 
the well -esta blished fact, which we have con-
firmed , that increased mitos is, in creased DNA 
syn thes is, a nd epiderm al hyperpl as ia occur in 
ha irless mouse epidermis 48 to 72 hr after ul t rav io-
let light irradi a tion (1 7 ). Hairless mouse skin is 
ad van tageo us not only beca use of t h e ease of 
application of to pica l agents, bu t because it also 
resembles human skin in having simila r penetra-
tion characte ristics [18 J. Because the preparation 
of t issues for mi tot ic coun ts and autoradiogra phy 
are t ime-consuming and t he counting of mi toses 
and la beled ce lls are subject to observer error, t he 
model has been made simpler by extracting radio-
actively label ed DNA from the mouse epidermis. 
A compound is considered to have ant iproliferative 
pote nti a l if t he in corporation of the isotope in to 
DNA is inhibited , correlating wi t h decreased mi -
toti c acti vi ty. 
MATERI ALS A 0 M ETHODS 
The dorsa l skin of 3- to 4- month ·o ld ra ndo m-bred 
ha irless mice (HRS/J stra in ) of e it her sex was irrad iated 
wi t h a ge rmi cida l la mp (Genera l El ec tric G T5) a t 20 cm 
for 6 min. At 1,7.24, ;31. and 48 hr a fte r irradi a t ion, 0. 1 
ml of t he topical age nt under ilwest iga tion was applied to 
th e nec k of the a nim a l. whi ch was th en immo bili zed fo r 
20 min so that it could not remove the tes t mate ri al. T he 
pos te rior half of the dorsal skin (hence forth called th e 
back) was left untrea ted a nd was used to moni to r for 
syste mic a bsorption . A syste mic drug, c.vc lophos ph am-
id e, was a lso in ves tiga ted and was gil·en in a dose of 150 
mg/kg in t ra peritonea lly at 48 hr . At 53 hI' a ll t he a ni ma ls 
were given 25 !l C i of triti a ted t hvmid ine (Am ersham/ 
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Searle) with a specific activity of 15.7 !,Ci/mM intraperi -
toneall~' a nd sac rifi ced a t 54 hr usinl( ether inh alat ion . 
The neck a nd back skins were removed sepa ra tely a nd 
biopsies were taken from each for mitot ic cou nts (ex -
pressed as nu mber of mitoses per 1000 interfollicul a r 
basal cell s \. For DNA extract ion. the epid ermis was 
separa ted from the dermis by pl acin l( th e skin derm is 
down on a plate heated a t 55°C for I min. The ep idermis 
could th en be peeled ofT eas ily with a sca lpel. Th e 
epid ermis was wra pped in a luminum foil , frozen in li quid 
nitrol(en , a nd sto red in a freezer at - 20°C unt il req uired . 
Approxim a te ly :]0 ml( of epide rmis was taken a nd th e 
ep iderma l ce lls were lysed in a tissue grind er (Py rex 772.',) ) 
in 4 ml of a solution containin g 8 M urea, 1°1r sod ium 
dodecyl s ul phate 119 \, 10 - 3 M ethylened ia mine tetra a-
c_et ic acid , a nd 0.24 M sod ium phos phate buffer, pH 6.8, 
and then forced twice through 26-gauge needles. F ive 
milili te rs of chloroform were added to the homogenate 
at room temperature l201 and the sa mple was shaken in 
a sealed, glass- toppered , 15- ml, Pyrex centrifuge tube 
for 15 min using a rotator (Balt imore B iolog ical Labora-
tory). T he tube was centrifuged at 2,200 rpm for 10 min 
and the supern atant containin g nucl e ic ac ids was care-
TABLE I. Effects on mitosis and DNA sy nthesis of UVL 
irradiation of ha irle.~s m ouse epidermis 
Epidermis No.or Site Mitotic cpm/ IO I'g 
animals index D A 
Non- 10 Neck 8 ± 4 250 ± 39 
irradiated Back 11 ± 3 410 ± 100 
54 hr a fter 10 Neck 44 ± 14 1250 380 
irrad iation Back 54 ± 15 l420 540 
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fu lly h and pipetted away from the den atured proteins 
at the in te rface into a 30-ml Corex (8445) centrifu ge 
tube. Two volum es of absolute eth anol (USP reagent 
quality) were added and mi xed well to precipitate the 
nucle ic ac ids at - 20 °C. After l2 hr the sample was cen-
tr ifuged at 6,500 rpm at 4°C and the tube was drained 
leavin g the prec ipitated nucle ic acids adherin g to the 
tube. These were solubili zed in 5 m l of SSC bulTer (0. 15 
M NaC I, 0.O l5 M sodium citrate, pH 7.0) and RNA 
was diges ted wit h 50A RNAse (S igma R487,) DNAse- free 
in 2 x SSC, pH 7.()) at :17 °C for 45 min. The sample \\'a 
shaken with chl oroform and centri fuged as above . The 
supernatant was removed and any re m a inin g prote in 
diges ted with 50A pronase at :17 °C for 4:) min a nd the 
ch lorofo rm procedure repeated . Two volum es of pure 
ethanol were add ed as hefore to precipita te D IA lem'in g 
RNA in so lution . 
After overnight precipit.at ion th e s amp le was cen -
tr ifu ged at 6.500 rpm for 10 min and the precipitated 
DNA solublized in Tris buller (0.2 M T ris. lO " EDT A 
pH 8.01 a nd di luted so tha t the D A absorbance rou ld b~ 
measured at 260 nm (Bec kman Mod el 25 spect rop hotom-
ete r) . One opti ca l density un it is a pproxim ate ly equal to 
50 !,g/ ml DNA 12 ll . [f'the A"",:A 2 . " ra tio was less than 1.7 
the alcohol prec ipit at ion was repeated. Thi s rat io is a n 
indicat ion of prote in contam ination and should be 
greater than 1.7 for accurate and cons is tent res ults . 
A I -ml sa mple of the resoluhi lized DNA was prepared 
for li quid sc in t ill a ti on counting by adding 1. :1 ml 50% 
trichloroacetic ac id (TCA) and keepi ng the mixture at 
O°C for at least :30 min. The DNA precipit a te was 
coll ected onto glass- fib er filter pa per (Whatma n) and 
washed with lO ml of' 5'1, cold T CA (0- 4°C) followed by 
95% ethanol to remove TCA and redu ce quenchin g. The 
filte rs were dried, p laced in :3 m l of to luene-omnifluor 
T ABLE n. Effects of antimetabolites 
Drug No. of Site" Mitotic cpm/ IO Il l' DNA animals index 
2% 5-f1 uorourac il in propy lene glycol" 19 Neck 8 ± 5 
Back 46 ± 16 
P ropylene glycol" 16 Neck 43 ± II 
Back 47 ± 12 
2% nitrogen mustard in water" 12 Neck 6 ± 4 320 ± 240 
Back 46 ± 11 1300 300 
Water" 13 Neck 42 ± 11 1200 ± 380 
Back 48 ± 8 1260 300 
1 % cyclop hosp hamide in propylene glycol" 10 Neck 41 ±o l4 1260 ± 390 
Back 57 ± l4 1690 ± 580 
Propylene glycol" 10 Neck 51 ± 13 1360 ± 520 
Back 56 13 1470 ± 330 
Cyclophosphamide (150 mg/kg)' 19 Back 15 11 310 ± 250 
Saline' 11 Back 63 ± 20 1510 ± 650 
a In each case when topica l appli cation was eva luated , the neck was the t reated a rea and the back was left un treated 
and used to monitor for a possible systemic effect of the agent. 
"Topical appli cations at 1, 7, 24, 31, and 48 hours a fter UVL. 
'lntraperi toneally at 48 hours after UVL. 
In a ll cases, animals were sacrificed 54 hours after UVL. 
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(New Engla nd Nucl ear) scintill at ion fluid and co un ted 
fo r 10 min in a Bec kman LS-150 sC In t illat IOn spect ro-
photom eter. The resul ts were ex pressed as counts per 
m inute per 10 p.g DNA. 
RESULTS 
The in creased mi tos is a nd D N A sy n thes is whi ch 
ccur 54 hI' a fte r ultrav io let light irradi at ion of ~airI ess mou.~e e pidermis in compa rison with unir-
adiated e pidermis are de mo nstra ted T able I. The 
r ffe ct o n mitos is of topical 2% 5- flu orourac il in 
e ro p y l e ne g lycol a pplied to t he necks o f 19 mice is 
Phow n in Table II in compa rison to the effect of ~ropylene g lyc?l alone i~ 16 mice. The e~fects on 
m itos is of t opical 2% m t rogen mustard JJ1 water 
. 12 mice, topica l 1% cyclophosphamide in pro-
;yle n e g lyco l in 10 mi ce, a nd of systen:ic cyc.lo-
h ospha m id e JJ1 19 mice and the comparison with 
f he res ul ts obta ined us ing the DNA ex t rac t ion 
p rocedure a re also shown in T able II . 
DISCUSSION 
Topical 5-fluo rouracil is known to inhibit t hy mi -
d l ate syn t hetase in t he s kin bloc kin g t he conver-si~n of deoxyuridine-5 mono~hosph.ate to t hy mi -
di n e -5 m o n o phosphate, t hu.s JJ1hlbl t ~ ~g J?N~ syn-
thes is a nd mitos l ~ [22 ] .. It ~ s ve:y e ff ective I.n our 
system in reduc lll g mitos Is wi t hou t exert ll1g a 
system ic effect . 
Becau se 5- tluorourac il does not preven t the in-
or por at ion of radioactive thymidine in to DNA ~22], we used cy clophos~h a~ide s~s~em ica lly, 
wh icn is known to be effective 111 pson as ls [23 ], to 
test o ur D N A extraction m ethod . The resu lts 
showed t h at the drug reduced the counts per 
minu te per 10 J.L g DNA 4-fold in comparison wi t h 
contr o ls, a nd t he mitotic index was simila rly 
decreased (T a b . II) . 
To d e m o n s trate th a t our DNA e x t ract ion 
meth o d is e ffect ive in detecting t he effects of 
antirtl etabo li tes topically,' 2:0 ni t rogen .mustard in 
water , whic h clears psonas ls [1 ] a nd IS known to 
reduc e t he mi totic index in t he mouse vagina 
mod e l [23 ], was invest igat ed . Table II s hows t hat 
the r e duced mitot ic counts a re well re f1 ected by the 
reduc ed cpm per 10 J.L g D NA. Furt hermore, t he 
nitr ogen mustard is shown to act locally on the 
neck epidermis because mitos is and DNA synthe-
sis in t h e epidermis of the backs of t he t reated 
anim a ls are un affected. All these res ul ts were 
founo. t o be s ignificant at the 1% level. T opica l '!. % 
cyclo phos phamide in propylene glycol , however , 
was ineffective in reduc ing mitos is a nd DNA 
Synti'le s is, which a lso correlates wi t h Va n Scott and 
Yu's work [24]. It is a lso ineffective in psori asis 
(per sonal 0 bserv a tion) . 
ThUS a s imple system has been dev ised in a 
small hairl ess animal for testing topical a nd sys-
tem ic drugs for antipro\ifera tive properties in the 
epide rmis. 
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